Literature DB >> 29423505

Laboratory Eligibility Criteria as Potential Barriers to Participation by Black Men in Prostate Cancer Clinical Trials.

Marie E Vastola1, David D Yang1, Vinayak Muralidhar2, Brandon A Mahal2, Christopher S Lathan1, Bradley A McGregor1, Paul L Nguyen1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29423505      PMCID： PMC5885818          DOI： 10.1001/jamaoncol.2017.4658

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  5 in total

1.  Cancer statistics for African Americans, 2016: Progress and opportunities in reducing racial disparities.

Authors:  Carol E DeSantis; Rebecca L Siegel; Ann Goding Sauer; Kimberly D Miller; Stacey A Fedewa; Kassandra I Alcaraz; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2016-02-22       Impact factor: 508.702

2.  Neutrophil count in African Americans: lowering the target cutoff to initiate or resume chemotherapy?

Authors:  Matthew M Hsieh; John F Tisdale; Griffin P Rodgers; Neal S Young; Edward L Trimble; Richard F Little
Journal:  J Clin Oncol       Date:  2010-03-01       Impact factor: 44.544

3.  Prevalence of neutropenia in the U.S. population: age, sex, smoking status, and ethnic differences.

Authors:  Matthew M Hsieh; James E Everhart; Danita D Byrd-Holt; John F Tisdale; Griffin P Rodgers
Journal:  Ann Intern Med       Date:  2007-04-03       Impact factor: 25.391

4.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

5.  Participation in cancer clinical trials: race-, sex-, and age-based disparities.

Authors:  Vivek H Murthy; Harlan M Krumholz; Cary P Gross
Journal:  JAMA       Date:  2004-06-09       Impact factor: 56.272
  5 in total
  5 in total

1.  Frequency of benign neutropenia among Black versus White individuals undergoing a bone marrow assessment.

Authors:  Scott C Borinstein; David Agamasu; Jonathan S Schildcrout; Lisa Bastarache; Minoo Bagheri; Lea K Davis; Dan M Roden; C Michael Stein; Sara L Van Driest; Jonathan D Mosley
Journal:  J Cell Mol Med       Date:  2022-06-01       Impact factor: 5.295

2.  Participation of Black Americans in Cancer Clinical Trials: Current Challenges and Proposed Solutions.

Authors:  Muhammad Awidi; Samer Al Hadidi
Journal:  JCO Oncol Pract       Date:  2021-05

3.  African American participation in cancer clinical trials.

Authors:  Jordan Swaby; Ernie Kaninjing; Motolani Ogunsanya
Journal:  Ecancermedicalscience       Date:  2021-10-25

Review 4.  Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Laboratory Reference Ranges and Testing Intervals Work Group.

Authors:  Alexander I Spira; Mark D Stewart; Suzanne Jones; Elaine Chang; Anitra Fielding; Nicole Richie; Laura S Wood; Michael A Thompson; Lee Jones; Abhilasha Nair; Brandon A Mahal; David E Gerber
Journal:  Clin Cancer Res       Date:  2021-02-09       Impact factor: 13.801

5.  Isolated Neutropenia/Benign Ethnic Neutropenia: A Common Clinical and Laboratory Finding in Southern and Western Saudi Arabia.

Authors:  Zuhier A Awan; Saeed M Al Amoudi; Muhammad Saboor; Husain Y Alkhaldy
Journal:  Int J Gen Med       Date:  2021-02-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.